Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QP-6211 for Injection in Post-hemorrhoidectomy Analgesia
ChiCTR2500106434Phase 3Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of QP-6211 in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: NRS-R-AUC0-72h. Started Jul 2025; status: recruiting.
02
Drugs
QP-6211
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500106434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106434.